14 Sep - 15 Sep '19

1st ECTORS meeting

The content of this meeting is centred around the state of the art of regenerative medicine in organ transplantation and its road to clinical application.

1st ECTORS meeting

Regenerative medicine in organ transplantation

Programme Information:

SATURDAY 14TH SEPTEMBER


BELLA SKY – ROOM ECTORS


 


09:00 – 19:00 first ECTORS meeting


09:00 – 09:30            Welcome and review 2008 - 2018


Marc Dahlke, Regensburg, Germany

Martin Hoogduijn, Rotterdam, The Netherlands


09.30-11.00   Session 1: Stem cells new developments


Chairs:                     

Marc Dahlke, Regensburg, Germany

Martin Hoogduijn, Rotterdam, The Netherlands


MSC mechanisms of action

Francesco Dazzi, London, United Kingdom


MSC in organ injury

Rafael Kramann, Aachen, Germany


Liver organoids from adult stem cells

Luc van der Laan, Rotterdam, The Netherlands


 


11.00-11.30 Coffee/tea


 


11.30-13.00 Session 2: Cell therapy clinical trials


Chairs:                      to be announced


 


MSC in clinical kidney transplantation

Giuseppe Remuzzi, Bergamo, Italy


 


From phase 1 to phase 2 clinical trials with MSC in kidney transplantation

Marlies Reinders, Leiden, The Netherlands


 


Lessons learned from stem cell clinical trials

Jens Kastrup, Copenhagen, Denmark


 


13.00-14.00 Lunch


14.00-15.30 Session 3: Organ reconditioning


Chairs:                      to be announced


Kidney machine perfusion

Sarah Hosgood, Cambridge, United Kingdom


Liver machine perfusion

Nicholas Gilbo, Leuven, Belgium


Regeneration on the pump

Rutger Ploeg, Oxford, United Kingdom


 


15.30-16.00 Coffee/tea


 


16.00-17.30 Session 4: Corporate session


to be announced


 


 


 


 


 


SUNDAY 15TH SEPTEMBER


BELLA CENTER – ROOM ECTORS


9.00-10.00 Session 5: Abstract presentations


Chairs:                      to be announced


 


10.00-10.50   Keynote lecture: Kidney organoids

to be announced


 


10.50-11.20 Coffee/tea


 


11.20-12.50 Joint session with VCA and BSC as part of ESOT2019


VCA quo vadis?


Chairs:                      to be announced


11:20 – 11:50            Advances in organ preservation and machine perfusion: potential impact on VCA

Annemarie Weissenbacher, Oxford University, UK / Innsbruck Medical University, Austria


11:50 – 12:20            Thinking outside the box: Combining VCA and regenerative medicine?

Robert Rieben, Bern, Switzerland


 


12:20 – 12:50            Cell-based immunoregulation and tolerance induction: are we getting any closer?

Fadi Issa, Oxford University, United Kingdom


 


12.50 Closing